Goldman Sachs’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $56.5K | Sell |
|
|||||
|
2022
Q4 | $167K | Sell |
|
|||||
|
2022
Q3 | $118K | Sell |
|
|||||
|
2022
Q2 | $324K | Buy |
|
|||||
|
2022
Q1 | $380K | Sell |
|
|||||
|
2021
Q4 | $1.17M | Buy |
|
|||||
|
2021
Q3 | $1.47M | Buy |
|
|||||
|
2021
Q2 | $1.48M | Sell |
|
|||||
|
2021
Q1 | $1.44M | Buy |
|
|||||
|
2020
Q4 | $1.03M | Buy |
|
|||||
|
2020
Q3 | $369K | Buy |
|
|||||
|
2020
Q2 | $378K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $246K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $81K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $194K | Buy |
|